Transfer Technology, Inc. FDA Inspection Record

FEI 3009494532 · Inspections, Form 483s, warning letters and import refusals

Transfer Technology, Inc. is an FDA-registered facility (FEI 3009494532) located in Huntington Beach, CA, US. Registered operations: LABEL; MANUFACTURE; PACK; RELABEL; REPACK. RegDataLab tracks 5 FDA inspections at this facility.

Reviewing Transfer Technology, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Transfer Technology, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

What FDA found at this site

Latest inspection
Apr 30, 2025: Voluntary Action Indicated (VAI)
Inspections on record
5 (4 VAI, 1 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Apr 30, 2025Voluntary Action Indicated (VAI)Design changes - Lack of or Inadequate Procedures (21 CFR 820.30(i))
Lack of or inadequate procedures (21 CFR 820.100(a))
Sampling plans (21 CFR 820.250(b))
Apr 28, 2023Voluntary Action Indicated (VAI)Procedures not in writing, fully followed (21 CFR 211.22(d))
Apr 13, 2021Voluntary Action Indicated (VAI)DHR - not or inadequately maintained (21 CFR 820.184)
Design control - no procedures (21 CFR 820.30(a))
Lack of or inadequate procedures (21 CFR 820.100(a))
Lack of or inadequate procedures for labeling (21 CFR 820.120)
and 3 more
Oct 11, 2019No Action Indicated (NAI)DHR - not or inadequately maintained (21 CFR 820.184)
Procedures not adequately established or maintained (21 CFR 820.40)
Design input - documentation (21 CFR 820.30(c))
Design transfer - Lack of or inadequate procedures (21 CFR 820.30(h))
and 8 more
Sep 17, 2013Voluntary Action Indicated (VAI)Design plans - Lack of or inadequate (21 CFR 820.30(b))
Design validation- Lack of or inadequate procedures (21 CFR 820.30(g))
Design transfer - Lack of or inadequate procedures (21 CFR 820.30(h))
DMR production process specifications (21 CFR 820.181(b))
and 8 more

Facility details

Company
Transfer Technology, Inc.
Location
Huntington Beach, CA (US)
Registration Expires
Dec 31, 2026
Operations
LABEL; MANUFACTURE; PACK; RELABEL; REPACK
Source
decrs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.